Key result
Natto red yeast rice reduces LDL-C ~13% vs placebo but adds no benefit to simvastatin.
Why the study?
Does Natto Red Yeast Rice (NRYR) supplementation (1,950 mg/d), alone or combined with simvastatin (20 mg/d), lower LDL-C levels at 3 months in adults with mild-to-moderate elevated LDL-C?
RCT (n=1,110)
Double-blind, double-placebo
Online central randomization system (Interactive Web Response System) into 4 groups (2x2 factorial design)
Yes
Does Natto Red Yeast Rice (NRYR) supplementation (1,950 mg/d), alone or combined with simvastatin (20 mg/d), lower LDL-C levels at 3 months in adults with mild-to-moderate elevated LDL-C?
Answers are grounded in this paper and cite their sources.
Natto Red Yeast Rice supplementation alone significantly reduces LDL-C by 13.2% over 3 months in Chinese adults with mild-to-moderate hypercholesterolemia, offering a well-tolerated lipid-lowering option, though its incremental benefit on top of simvastatin 20 mg/d attenuated by 3 months.
BACKGROUND: Natto Red Yeast Rice (NRYR) is a dietary supplement used to lower blood lipid. However, evidence on its effects on regulating lipid levels is limited. OBJECTIVES: The aim of this study was to assess whether NRYR can lower low-density lipoprotein cholesterol (LDL-C) levels and regulate other lipids, both alone and in addition to simvastatin. METHODS: We enrolled 1,110 participants who were randomized into 4 groups to receive a 3-month intervention of placebo, NRYR (1,950 mg/d), simvastatin (20 mg/d), or NRYR (1,950 mg/d) plus simvastatin (20 mg/d). The primary outcome was the change in LDL-C levels after 3 months, which were evaluated using linear mixed models. The primary analyses were conducted according to the modified intention-to-treat principle. Safety outcomes were also recorded. RESULTS: Significant reductions in LDL-C levels were observed in the NRYR, simvastatin, and combination group. The differences in the absolute/percent change in LDL-C levels from baseline to 3 months were -21.02 mg/dL (95% CI: -27.98 to -14.06 mg/dL)/-13.21% (95% CI: -17.88% to -8.54%), -25.80 mg/dL (95% CI: -32.64 to -18.97 mg/dL)/-17.08% (95% CI: -21.67% to -12.50%), and -32.74 mg/dL (95% CI: -39.74 to -25.73 mg/dL)/-21.22% (95% CI: -25.92% to -16.52%), respectively, compared with placebo (all P < 0.001). Compared with simvastatin alone, adding NRYR demonstrated a significant decrease in LDL-C levels with a net absolute/percent change of -7.95 mg/dL (95% CI: -13.79 to -2.11 mg/dL; P = 0.008)/-5.05% (95% CI: -8.87% to -1.24%; P = 0.009) at 1 month, but the effect was not significant at 3 months. Adverse event rates were similar across the 4 groups. CONCLUSIONS: NRYR alone lowered LDL-C levels, and its combination with simvastatin was associated with numerically but not significantly lower LDL-C levels than using simvastatin alone. (ChiCTR2200064214, ChiCTR2200064215).
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) conducted an RCT in Dyslipidemia (mild-to-moderate elevated LDL-C) (n=1,110). Natto Red Yeast Rice (NRYR) supplement alone or combined with simvastatin vs. Placebo (NRYR placebo + simvastatin placebo) or simvastatin 20 mg/d monotherapy was evaluated on Change from baseline in LDL-C level at 3 months (NRYR alone vs placebo) (MD -21.02 mg/dL (-13.21%), 95% CI -27.98 to -14.06, p=<0.001). Natto Red Yeast Rice reduced LDL-C by /dL vs placebo at 3 months, but adding it to simvastatin did not lower LDL-C vs simvastatin alone at 3 months.
Synapse has enriched 10 related papers. Consider them for comparative context: